Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Share Incentive Plan

7 Nov 2008 08:00

RNS Number : 6818H
ABCAM Plc
07 November 2008
 



For immediate release 

7 November 2008

ABCAM PLC

 ("Abcam" or "the Company")

Share Incentive Plan

As a result of transactions on 6 November 2008 by the Abcam plc Share Incentive Plan (an HMRC approved all employee share purchase plan adopted by the Company's shareholders at the Company's AGM on 3 November 2008), Jonathan Milner, Jeff Iliffe and Jim Warwick, Executive Directors of the Company, have the following interests as a result of their participation in the Plan:

Free Shares awarded on 6 November 2008 at £4.62 per share

Total number of Shares held in the Plan on 6 November 2008

Jonathan Milner

649

649

Jeff Iliffe

649

649

Jim Warwick

649

649

The beneficial ownership of the Free Shares will pass to the Executive Directors on 6 November 2011 subject to their continued employment.

For further information please contact: 

Abcam

+ 44 (0) 1223 696000

Jeff Iliffe, Chief Financial Officer

Numis Securities

+ 44 (0) 207 260 1000

Nominated Adviser: Nick Westlake, Michael Meade

Corporate Broking: James Black

Buchanan Communications

+ 44 (0) 20 7466 5000

Mark Court / Mary-Jane Johnson / Stasa Filiplic

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAKFXEAAPFEE
Date   Source Headline
29th Oct 20212:42 pmRNSTotal Voting Rights
27th Oct 20217:00 amRNSCompletion of BioVision Acquisition
12th Oct 20214:46 pmRNSHolding(s) in Company
11th Oct 20214:21 pmRNSBlock listing Interim Review
6th Oct 202110:35 amRNSHolding(s) in Company
24th Sep 20214:03 pmRNSDirector/PDMR Shareholding
13th Sep 202112:00 pmRNSInterim results for the 6 and 12 month periods
1st Sep 20214:02 pmRNSTotal Voting Rights
1st Sep 202112:00 pmRNSTransition Report on 20-F and Notice of Results
17th Aug 20217:52 pmEQSThis is a test - Please ignore
13th Aug 20217:00 amRNSDirectorate Change
2nd Aug 202112:57 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSAbcam to Acquire BioVision for $340 million
9th Jul 20212:34 pmRNSBlock listing Interim Review
1st Jul 20214:22 pmRNSTotal Voting Rights
1st Jul 20214:03 pmRNSResult of General Meeting
1st Jul 202112:00 pmRNSPre-Close Trading Update
2nd Jun 20219:54 amRNSTotal Voting Rights
2nd Jun 20218:30 amRNSNotice of Year End Change and General Meeting
19th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTotal Voting Rights
1st Apr 20213:11 pmRNSTotal Voting Rights
12th Mar 20212:55 pmRNSDirector/PDMR Shareholding
11th Mar 202111:46 amRNSDirector/PDMR Shareholding - Replacement
10th Mar 20214:50 pmRNSDirector/PDMR Shareholding
8th Mar 202112:02 pmRNSInterim Results for 6 months ended 31 Dec 2020
1st Mar 20215:08 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSNotice of Results
17th Feb 202112:00 pmRNSAbcam presenting at the SVB Leerink Conference
4th Feb 20213:24 pmRNSDirector/PDMR Shareholding
1st Feb 20219:27 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSDirectorate Change
14th Jan 20213:26 pmRNSHolding(s) in Company
11th Jan 202112:00 pmRNSHalf year trading update
4th Jan 202111:03 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSAbcam plc presenting at JPM Healthcare Conference
21st Dec 20207:00 amRNSNotification of Trading Update
17th Dec 20209:35 amRNSHolding(s) in Company
4th Dec 20202:32 pmRNSResult of AGM
1st Dec 20204:46 pmRNSTotal Voting Rights
4th Nov 202010:33 amRNSDirector/PDMR Shareholding
3rd Nov 20201:30 pmRNSConsultation on 2020 LTIP Awards
3rd Nov 20201:30 pmRNSAnnual Report, Impact Report and Notice of AGM
2nd Nov 202010:49 amRNSTotal Voting Rights
26th Oct 20203:45 pmRNSAbcam Announces Closing of Offering
23rd Oct 20207:00 amRNSExercise of Over-allotment Option
22nd Oct 20207:00 amRNSPricing of Offering on NASDAQ
19th Oct 202012:15 pmRNSOffering and Application to List on Nasdaq
5th Oct 20207:01 amRNSRegistration Statement for Proposed Offering Filed
5th Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.